We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Illumina

Illumina develops, manufactures and markets integrated systems for the analysis of genetic variations and biological ... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

New Virus Identified in Blood Supply

By LabMedica International staff writers
Posted on 30 Sep 2015
Print article
Image: The HiSeq 2500 sequencing platform (Photo courtesy of Illumina).
Image: The HiSeq 2500 sequencing platform (Photo courtesy of Illumina).
Transfusion of blood or blood-derived products can save lives and improve health but requires safety measures for preventing bystander transmission of infectious agents.

To investigate the transmission of novel infectious agents by blood transfusion, changes in the virome composition of blood transfusion recipients pre- and post-transfusion has been studied.

An international group of scientists led by those at Columbia University (New York, NY, USA) collected serum samples from four participating blood centers distributed across the USA from July 1974 through June 1980. They performed high-throughput sequencing on blood samples from 46 individuals in the in the Transfusion-Transmitted Viruses Study (TTVS). They also performed high-throughput sequencing on samples from 106 individuals in the Multicenter Hemophilia Cohort Study who received plasma-derived clotting factor concentrates.

Total ribonucleic acid (RNA) extracts were reverse transcribed using a SuperScript III kit (Invitrogen Life Technologies; Carlsbad, CA, USA) with random hexamer primers. After processing, samples with low concentrations were amplified by increasing polymerase chain reaction (PCR) cycle numbers from 9 to 14. All sequencing was done on the Illumina HiSeq 2500 platform (Illumina; San Diego, CA, USA), yielding an average of 150 million reads per sequencing lane.

The team analyzed samples both pre- and post-transfusion and along with a variety of known viruses, they identified a new virus in two individuals. The virus was only present in post-transfusion samples, and additional tests showed that both patients were able to clear the virus. Genetic analysis determined that the novel human virus, human hepegivirus 1 (HHpgV-1) was related to Hepatitis C virus (HCV) and human Pegivirus (HPgV; formerly called GB virus C or Hepatitis G virus). Genomic testing of 70 additional individuals in the TTVS study failed to detect further cases of the virus detected. HHpgV-1 was found in serum samples from two blood transfusion recipients and two hemophilia patients who had received plasma-derived clotting factor concentrates.

Amit Kapoor, PhD, an assistant professor and lead author of the study said, “HHpgV-1 is unique because it shares genetic similarity with both highly pathogenic HCV and the apparently non-pathogenic HPgV. People need to be aware of this new infection in humans. We just don't know how many viruses are transmitted through the blood supply. There are so many viruses out there, and they need to be characterized in order to ensure that transfusions are safe.” The study was published on September 22, 2015, in the journal mBio.

Related Links:

Columbia University 
Invitrogen Life Technologies
Illumina 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.